Materne North America Corporation in Nampa underwent an inspection by the Food and Drug Administration (FDA) on Feb. 13 focusing on foodborne biological hazards, according to data posted on the FDA’s website.
The inspection report concluded that Materne North America Corporation was not required to take corrective action regarding its operations management.
The FDA regularly inspects facilities nationwide to assess whether workplaces and their products meet regulatory standards designed to protect public health. Results from these inspections are made available to the public.
According to its website, the FDA is a federal agency chiefly tasked with oversight of the production and distribution of drugs, biological products, medical supplies and tobacco items to ensure their safety and quality.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
